Sorensen Mel, President and CEO of Galera Therapeutics, Inc. ($GRTX), made one open market sale of common shares worth $1,407 in the last 365 days, with the most recent on November 20, 2025. This ranks 11,531st among 11,678 insiders in our database, where the average sale totals $8.6 million across 6.4 transactions. Sorensen Mel reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2025 | Galera Therapeutics, Inc. | $GRTX | Sorensen Mel | President and CEO | S | Common Stock | 70000 | $0.02 | 195,029.0000 | 98,503,430 | 26.41% | 0.07% |
| May 1, 2025 | Galera Therapeutics, Inc. | $GRTX | Sorensen Mel | President and CEO | A | Stock Option (Right to Buy) | 6000000 | $0.00 | 6,000,000.0000 | 54,633,215 | 9999.99% | 10.98% |
| Aug. 16, 2024 | Galera Therapeutics, Inc. | $GRTX | Sorensen Mel | President and CEO | S | Common Stock | 67015 | $0.07 | 265,029.0000 | 44,549,285 | 20.18% | 0.15% |
| March 10, 2023 | Galera Therapeutics, Inc. | $GRTX | Sorensen Mel | President and CEO | P | Common Stock | 100000 | $1.68 | 332,044.0000 | 0 | 43.10% | 0.00% |
| Feb. 25, 2023 | Galera Therapeutics, Inc. | $GRTX | Sorensen Mel | President and CEO | A | Stock Option (Right to Buy) | 440000 | $0.00 | 440,000.0000 | 0 | 9999.99% | 0.00% |